Skip to main content
SpringerLink
Log in

Statintherapie bei Herzinsuffizienz

CORONA-Studie (Controlled Rosuvastatin Multinational Trial in Heart Failure)

Statin therapy for systolic heart failure. The CORONA trial (Controlled Rosuvastatin Multinational Trial in Heart Failure)

  • Klinische Studien
  • Published:
Der Internist Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Cleland JG, Coletta AP, Abdellah AT et al. (2008) Clinical trials update from the American Heart Association 2007: CORONA, RethinQ, MASCOT, AF-CHF, HART, MASTER, POISE and stem cell therapy. Eur J Heart Fail 10: 102–108

    Article  PubMed  Google Scholar 

  2. Kalantar-Zadeh K, Horwich TB, Oreopoulos A et al. (2007) Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care 10: 433–442

    Article  PubMed  Google Scholar 

  3. Ramasubbu K, Estep J, White DL et al. (2008) Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy. J Am Coll Cardiol 51: 415–426

    Article  PubMed  CAS  Google Scholar 

  4. Rauchhaus M, Clark AL, Doehner W et al. (2003) The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol 42: 1933–1940

    Article  PubMed  CAS  Google Scholar 

  5. Shepherd J, Blauw GJ, Murphy MB et al. PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk (2002) Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360: 1623–1630

    Article  PubMed  CAS  Google Scholar 

  6. Tavazzi L, Tognoni G, Franzosi MG et al.; GISSI-HF Investigators (2004) Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3-polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure. Eur J Heart Fail 6: 635–641

    PubMed  CAS  Google Scholar 

  7. Wanner C, Krane V, März W et al.; German Diabetes and Dialysis Study Investigators (2005) Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353: 238–248

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Medizinische Klinik und Poliklinik I, Uniklinik Würzburg, Klinikstraße 6–8, 97070, Würzburg, Deutschland

    C.E. Angermann

  2. Stuttgart, Deutschland

    S. Nitschmann

Authors
  1. C.E. Angermann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Nitschmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C.E. Angermann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Angermann, C., Nitschmann, S. Statintherapie bei Herzinsuffizienz. Internist 49, 884–886 (2008). https://doi.org/10.1007/s00108-008-2124-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-008-2124-x

Search

Navigation